|
Oct 4
|
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting
|
|
Jun 24
|
TScan Therapeutics Decline Means Insider Profits Down To US$54k
|
|
Jun 24
|
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
|
|
May 2
|
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
May 1
|
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Mar 7
|
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline
|
|
Mar 6
|
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 6
|
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Feb 19
|
TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?
|
|
Dec 23
|
Timothy Barberich Bought 41% More Shares In TScan Therapeutics
|
|
Dec 9
|
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
|
|
Dec 7
|
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
|
|
Dec 6
|
Recent Price Trend in TScan Therapeutics, Inc. (TCRX) is Your Friend, Here's Why
|
|
Dec 4
|
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
|
|
Dec 4
|
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
|
|
Dec 1
|
Does TScan Therapeutics, Inc. (TCRX) Have the Potential to Rally 62.33% as Wall Street Analysts Expect?
|
|
Nov 30
|
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
|
|
Nov 28
|
With TScan Therapeutics Up 12%, Insider Buyers Count Their Returns
|
|
Nov 27
|
TScan Therapeutics, Inc. (TCRX) is a Great Momentum Stock: Should You Buy?
|
|
Nov 9
|
TScan Therapeutics Inc (TCRX) Reports Q3 2023 Financial Results and Corporate Updates
|